Register free for our breaking news email alerts with analysis and cutting edge commentary from our award winning team. Registration only takes a minute.

Royal London US Growth Trust A Inc

Ranked 1486 out of 1886 in - US over 12 months
All calculations are in USD unless stated

Managed by

Thomas Digenan

Tom Digenan is head of the US Intrinsic Value Equity team at UBS Asset Management, and was previously president of the firm’s mutual funds and relationship funds organisation. He is a member of the CFA Institute and the American Institute of Certified Public Accountants, and is on the board of CFA Society Chicago. Tom was an adjunct professor in the Marquette University Graduate School of Business from 2012 to 2016.

Objective

The CIS US Growth Trust aims to provide above average capital growth from a diverse portfolio of US equities in any economic sector. The Trust’s portfolio will be concentrated on strong franchise companies. Cash generation and the prospects for dividend growth are major considerations when evaluating company outlooks.

Performance

US over : 30/09/2017 - 30/09/2018

Total Return

Quarterly Performance

to 30/09/2018 Annual Q1 Q2 Q3 Q4
2018 -3.1% 4.4% 3.0%
2017 20.7% 8.4% 2.1% 3.7% 5.2%
2016 10.0% -4.1% 0.9% 9.5% 3.9%
2015 -2.6% 3.1% 1.0% -12.8% 7.4%
2014 14.6% 2.0% 7.1% -0.8% 5.8%
2013 35.6% 13.3% 4.0% 7.0% 7.6%
2012 8.4% 12.0% -10.0% 9.4% -1.7%
2011 -3.7% 2.9% 0.3% -14.5% 9.2%
2010 12.0% 4.8% -12.9% 9.4% 12.2%
2009 36.1% -8.9% 20.7% 16.3% 6.5%
2008 -42.5% -10.5% -1.9% -12.0% -25.6%
2007 -0.1% 0.3% 6.7% -1.5% -5.2%
2006 13.6% 3.7% -1.7% 4.2% 6.9%
2005 3.3% -1.1% 0.6% 2.7% 1.2%
2004 8.2% 1.8% 1.1% -2.2% 7.5%
2003 25.0% -1.5% 12.7% 1.7% 10.9%
2002 -25.0% -2.3% -13.8% -15.9% 5.8%
2001 6.6% -15.9% 14.3%

Month by Month Performance

Returns Vs Risk

Asset Allocation

Breakdown

31/08/2018

Top 10 Holdings

Stock Size
Amazon.com Inc ORD 4.61%
Facebook Inc ORD 3.17%
Wells Fargo & Co ORD 2.94%
Marsh & McLennan Companies Inc ORD 2.88%
Philip Morris International Inc ORD 2.77%
American Express Co ORD 2.72%
JPMorgan Chase & Co ORD 2.54%
UnitedHealth Group Inc ORD 2.49%
Johnson & Johnson ORD 2.24%
Synchrony Financial ORD 2.18%
31/08/2018

Registered For Sale In

  1. United Kingdom

Fund Info

  • Launch date19/02/2001
  • Share Class size225Mn
  • Base currencyGBX
  • ISIN GB0030038359

Purchase Info

  • Min. initial investment100,000
  • Min. regular additional investment5,000

Charges

  • Annual management1.50%
  • Initial investment5.00%

Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated).